Industry: Pharma & Healthcare
Published Date: 2026-04-28
Pages: 108 Pages
Report ld: 5587839
Request Sample
Customized Report
Parenteral Excipients Market Size(US$)

CAGR 2026-2032
5.3%
Market Size,2032
USD 1,534
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Parenteral Excipients market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 1534 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Parenteral Excipients competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Parenteral excipients for injection are inactive ingredients used in injections, infusions, and lyophilized formulations. They primarily function to solubilize, stabilize, buffer, adjust tonicity, provide antioxidant protection, and protect the active ingredient, while meeting requirements for high purity, low endotoxin levels, and good injection safety.
Upstream suppliers mainly include pharmaceutical-grade sugars, amino acids, surfactants, buffer salts, chelating agents, antioxidants, solvents, aseptic packaging materials, and high-purity raw material suppliers. Downstream applications primarily target chemical injections, biopharmaceuticals, vaccines, liposomes, long-acting formulations, lyophilized powder injections, and CDMOs.
The global market price for parenteral excipients for injection is $7,511 per ton, with annual sales of approximately 142,000 tons and a global annual production capacity of approximately 180,000-200,000 tons. The industry profit margin is 15%.
The future global market for parenteral excipients for injection will move towards higher purity, higher functionality, and regulatory-driven upgrades. With the continued expansion of biologics, vaccines, complex injectable formulations, and high-concentration formulations, the market demand for excipients that solubilize, stabilize proteins/nucleic acids, control particulate matter and impurities, and improve compatibility and long-term storage performance will significantly increase. Simultaneously, regulatory agencies and pharmacopoeias are imposing stricter requirements on the quality attributes, impurity profiles, aseptic assurance, and specific application standards of injectable excipients, driving the supply chain towards greater consistency and traceability. On the other hand, multifunctional excipients, pre-formulated systems, and specialized excipients better suited for lipid nanoparticles, sustained-release injections, and biologics will become important directions.
This report delivers a comprehensive overview of the global Parenteral Excipients market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Parenteral Excipients. The Parenteral Excipients market size, estimates, and forecasts are provided in terms of sales volume (K Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Parenteral Excipients market comprehensively. Regional market sizes by Type, by Application, by Source, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Parenteral Excipients manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Parenteral Excipients manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Parenteral Excipients sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Parenteral Excipients Market Overview
1.1 Product Definition
1.2 Parenteral Excipients by Type
1.2.1 Global Parenteral Excipients Market Value by Type: 2025 vs 2032
1.2.2 Solubilizers
1.2.3 Bulker
1.2.4 Preservatives
1.2.5 Solvents
1.2.6 Others
1.3 Parenteral Excipients by Source
1.3.1 Global Parenteral Excipients Market Value by Source: 2025 vs 2032
1.3.2 Natural Source Excipients
1.3.3 Semi-Synthetic Excipients
1.3.4 Synthetic Excipients
1.3.5 Bio-Derived Excipients
1.4 Parenteral Excipients by Dosage Form
1.4.1 Global Parenteral Excipients Market Value by Dosage Form: 2025 vs 2032
1.4.2 Excipients for Injection
1.4.3 Excipients for Infusion
1.4.4 Excipients for Lyophilized Powder for Injection
1.4.5 Excipients for Emulsions/Suspensions
1.4.6 Excipients For Liposomes/Lnps
1.4.7 Others
1.5 Parenteral Excipients by Application
1.5.1 Global Parenteral Excipients Market Value by Application: 2025 vs 2032
1.5.2 Precision Medicine
1.5.3 Biopharmaceuticals
1.5.4 Others
1.6 Global Parenteral Excipients Market Size Estimates and Forecasts
1.6.1 Global Parenteral Excipients Revenue 2021–2032
1.6.2 Global Parenteral Excipients Sales 2021–2032
1.6.3 Global Parenteral Excipients Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Parenteral Excipients Market Competition by Manufacturers
2.1 Global Parenteral Excipients Sales Market Share by Manufacturers (2021–2026)
2.2 Global Parenteral Excipients Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Parenteral Excipients Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Parenteral Excipients, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Parenteral Excipients, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Parenteral Excipients, Product Types and Applications
2.7 Global Key Manufacturers of Parenteral Excipients, Date of Entry into the Industry
2.8 Global Parenteral Excipients Market Competitive Situation and Trends
2.8.1 Global Parenteral Excipients Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Parenteral Excipients Players Market Share by Revenue
2.8.3 Global Parenteral Excipients Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Parenteral Excipients Market Scenario by Region
3.1 Global Parenteral Excipients Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Parenteral Excipients Sales by Region: 2021–2032
3.2.1 Global Parenteral Excipients Sales by Region: 2021–2026
3.2.2 Global Parenteral Excipients Sales by Region: 2027–2032
3.3 Global Parenteral Excipients Revenue by Region: 2021–2032
3.3.1 Global Parenteral Excipients Revenue by Region: 2021–2026
3.3.2 Global Parenteral Excipients Revenue by Region: 2027–2032
3.4 North America Parenteral Excipients Market Facts & Figures by Country
3.4.1 North America Parenteral Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Parenteral Excipients Sales by Country (2021–2032)
3.4.3 North America Parenteral Excipients Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Parenteral Excipients Market Facts & Figures by Country
3.5.1 Europe Parenteral Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Parenteral Excipients Sales by Country (2021–2032)
3.5.3 Europe Parenteral Excipients Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Excipients Market Facts & Figures by Region
3.6.1 Asia Pacific Parenteral Excipients Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Parenteral Excipients Sales by Region (2021–2032)
3.6.3 Asia Pacific Parenteral Excipients Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Parenteral Excipients Market Facts & Figures by Country
3.7.1 Latin America Parenteral Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Parenteral Excipients Sales by Country (2021–2032)
3.7.3 Latin America Parenteral Excipients Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Parenteral Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Parenteral Excipients Sales by Country (2021–2032)
3.8.3 Middle East and Africa Parenteral Excipients Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parenteral Excipients Sales by Type (2021–2032)
4.1.1 Global Parenteral Excipients Sales by Type (2021–2026)
4.1.2 Global Parenteral Excipients Sales by Type (2027–2032)
4.1.3 Global Parenteral Excipients Sales Market Share by Type (2021–2032)
4.2 Global Parenteral Excipients Revenue by Type (2021–2032)
4.2.1 Global Parenteral Excipients Revenue by Type (2021–2026)
4.2.2 Global Parenteral Excipients Revenue by Type (2027–2032)
4.2.3 Global Parenteral Excipients Revenue Market Share by Type (2021–2032)
4.3 Global Parenteral Excipients Price by Type (2021–2032)
5 Segment by Application
5.1 Global Parenteral Excipients Sales by Application (2021–2032)
5.1.1 Global Parenteral Excipients Sales by Application (2021–2026)
5.1.2 Global Parenteral Excipients Sales by Application (2027–2032)
5.1.3 Global Parenteral Excipients Sales Market Share by Application (2021–2032)
5.2 Global Parenteral Excipients Revenue by Application (2021–2032)
5.2.1 Global Parenteral Excipients Revenue by Application (2021–2026)
5.2.2 Global Parenteral Excipients Revenue by Application (2027–2032)
5.2.3 Global Parenteral Excipients Revenue Market Share by Application (2021–2032)
5.3 Global Parenteral Excipients Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Parenteral Excipients Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Ashland
6.2.1 Ashland Company Information
6.2.2 Ashland Description and Business Overview
6.2.3 Ashland Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Ashland Parenteral Excipients Product Portfolio
6.2.5 Ashland Recent Developments/Updates
6.3 Roquette
6.3.1 Roquette Company Information
6.3.2 Roquette Description and Business Overview
6.3.3 Roquette Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Roquette Parenteral Excipients Product Portfolio
6.3.5 Roquette Recent Developments/Updates
6.4 Croda Pharma
6.4.1 Croda Pharma Company Information
6.4.2 Croda Pharma Description and Business Overview
6.4.3 Croda Pharma Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Croda Pharma Parenteral Excipients Product Portfolio
6.4.5 Croda Pharma Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BASF Parenteral Excipients Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 Evonik
6.6.1 Evonik Company Information
6.6.2 Evonik Description and Business Overview
6.6.3 Evonik Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Evonik Parenteral Excipients Product Portfolio
6.6.5 Evonik Recent Developments/Updates
6.7 Seppic
6.7.1 Seppic Company Information
6.7.2 Seppic Description and Business Overview
6.7.3 Seppic Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Seppic Parenteral Excipients Product Portfolio
6.7.5 Seppic Recent Developments/Updates
6.8 Lubrizol
6.8.1 Lubrizol Company Information
6.8.2 Lubrizol Description and Business Overview
6.8.3 Lubrizol Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lubrizol Parenteral Excipients Product Portfolio
6.8.5 Lubrizol Recent Developments/Updates
6.9 Pfanstiehl
6.9.1 Pfanstiehl Company Information
6.9.2 Pfanstiehl Description and Business Overview
6.9.3 Pfanstiehl Parenteral Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Pfanstiehl Parenteral Excipients Product Portfolio
6.9.5 Pfanstiehl Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Excipients Industry Chain Analysis
7.2 Parenteral Excipients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Excipients Production Mode & Process Analysis
7.4 Parenteral Excipients Sales and Marketing
7.4.1 Parenteral Excipients Sales Channels
7.4.2 Parenteral Excipients Distributors
7.5 Parenteral Excipients Customer Analysis
8 Parenteral Excipients Market Dynamics
8.1 Parenteral Excipients Industry Trends
8.2 Parenteral Excipients Market Drivers
8.3 Parenteral Excipients Market Challenges
8.4 Parenteral Excipients Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Parenteral Excipients market is projected to grow from US$ 1067 million in 2025 to US$ 1534 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-28
Pages: 138
USD 4900.00
(Single User License)
The global Parenteral Excipients market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 1534 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-04-28
Pages: 135
USD 4250.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 1534 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 130
USD 3950.00
(Single User License)
The global Parenteral Excipients market is projected to grow from US$ 1588 million in 2024 to US$ 2283 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 136
USD 4900.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 108
USD 3950.00
(Single User License)
The global Parenteral Excipients market size was US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 78
USD 4250.00
(Single User License)
The global market for Parenteral Excipients was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 2283 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 83
USD 2900.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 92
USD 3950.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1547 million in 2023 and is forecast to a readjusted size of US$ 2177 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 101
USD 3950.00
(Single User License)
The global market for Parenteral Excipients was valued at US$ 1547 million in the year 2023 and is projected to reach a revised size of US$ 2177 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-04
Pages: 86
USD 2900.00
(Single User License)
The global Parenteral Excipients market is projected to grow from US$ 1067 million in 2025 to US$ 1534 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-28
Pages: 138
The global Parenteral Excipients market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 1534 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-04-28
Pages: 135
The global market for Parenteral Excipients was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 1534 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 130
The global Parenteral Excipients market is projected to grow from US$ 1588 million in 2024 to US$ 2283 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 136
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 108
The global Parenteral Excipients market size was US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 78
The global market for Parenteral Excipients was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 2283 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 83
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 92
The global market for Parenteral Excipients was estimated to be worth US$ 1547 million in 2023 and is forecast to a readjusted size of US$ 2177 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 101
The global market for Parenteral Excipients was valued at US$ 1547 million in the year 2023 and is projected to reach a revised size of US$ 2177 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-04
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now